Morgan Stanley’s Monarch Blue Chips Elite Index ETF MBCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.1K Buy
2,165
+319
+17% +$12.2K ﹤0.01% 6302
2026
Q1
$63.7K Buy
1,846
+15
+0.8% +$546 ﹤0.01% 6326
2025
Q4
$67.6K Buy
1,831
+1,829
+91,450% +$67.3K ﹤0.01% 6340
2025
Q3
$94 Buy
+2
New +$73 ﹤0.01% 7695
2025
Q2
Sell
-1
Closed -$65 8212
2025
Q1
$65 Buy
+1
New +$35 ﹤0.01% 7651
2023
Q4
Sell
-1,515
Closed -$39K 7877
2023
Q3
$39K Hold
1,515
﹤0.01% 6270
2023
Q2
$40.8K Hold
1,515
﹤0.01% 6298
2023
Q1
$38.1K Hold
1,515
﹤0.01% 6382
2022
Q4
$35.9K Hold
1,515
﹤0.01% 6435
2022
Q3
$32K Hold
1,515
﹤0.01% 6597
2022
Q2
$34K Hold
1,515
﹤0.01% 6785
2022
Q1
$40K Hold
1,515
﹤0.01% 6806
2021
Q4
$45K Hold
1,515
﹤0.01% 6859
2021
Q3
$43K Buy
+1,515
New +$43.8K ﹤0.01% 6790

Other funds holding MBCE

Morgan Stanley's MBCE Position: Q2 2026 in Review

Morgan Stanley increased its Monarch Blue Chips Elite Index ETF (MBCE) stake by 17% in Q2 2026, buying an estimated $12.2K and bringing the position to 2,165 shares worth $90.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6302.

Morgan Stanley first reported a position in MBCE in Q3 2021 and has held it in 14 quarters since. 9 funds tracked by Wall St. Rank hold MBCE as of Q2 2026.

  • Morgan Stanley held 2,165 shares of Monarch Blue Chips Elite Index ETF worth $90.1K as of Q2 2026.
  • Morgan Stanley bought 319 Monarch Blue Chips Elite Index ETF shares in Q2 2026, an estimated $12.2K.
  • Monarch Blue Chips Elite Index ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6302 holding.
  • Morgan Stanley first reported a position in Monarch Blue Chips Elite Index ETF in Q3 2021 and has held it in 14 quarters since.
  • 9 funds tracked by Wall St. Rank held Monarch Blue Chips Elite Index ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.